These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 21499248)

  • 21. A genome-wide association study of HCV-induced liver cirrhosis in the Japanese population identifies novel susceptibility loci at the MHC region.
    Urabe Y; Ochi H; Kato N; Kumar V; Takahashi A; Muroyama R; Hosono N; Otsuka M; Tateishi R; Lo PH; Tanikawa C; Omata M; Koike K; Miki D; Abe H; Kamatani N; Toyota J; Kumada H; Kubo M; Chayama K; Nakamura Y; Matsuda K
    J Hepatol; 2013 May; 58(5):875-82. PubMed ID: 23321320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Control of progression towards liver fibrosis and hepatocellular carcinoma by SOCS3 polymorphisms in chronic HCV-infected patients.
    Jadid FZ; Chihab H; Alj HS; Elfihry R; Zaidane I; Tazi S; Badre W; Marchio A; El Filali KM; Tahiri M; Saile R; Pineau P; Ezzikouri S; Benjelloun S
    Infect Genet Evol; 2018 Dec; 66():1-8. PubMed ID: 30172885
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IL-28B rs12979860 C/T allele distribution in patients with liver cirrhosis: role in the course of chronic viral hepatitis and the development of HCC.
    Fabris C; Falleti E; Cussigh A; Bitetto D; Fontanini E; Bignulin S; Cmet S; Fornasiere E; Fumolo E; Fangazio S; Cerutti A; Minisini R; Pirisi M; Toniutto P
    J Hepatol; 2011 Apr; 54(4):716-22. PubMed ID: 21146242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IL17A gene polymorphism, serum IL17 and total IgE in Egyptian population with chronic HCV and hepatocellular carcinoma.
    ELBassuoni MA; Abd El Fatah G; Zaghla H
    Immunol Lett; 2015 Dec; 168(2):240-5. PubMed ID: 26367076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SNP rs2596542G>A in MICA is associated with risk of hepatocellular carcinoma: a meta-analysis.
    Wang H; Cao H; Xu Z; Wang D; Zeng Y
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 30967497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human leukocyte antigen variants and risk of hepatocellular carcinoma modified by hepatitis C virus genotypes: A genome-wide association study.
    Lee MH; Huang YH; Chen HY; Khor SS; Chang YH; Lin YJ; Jen CL; Lu SN; Yang HI; Nishida N; Sugiyama M; Mizokami M; Yuan Y; L'Italien G; Tokunaga K; Chen CJ;
    Hepatology; 2018 Feb; 67(2):651-661. PubMed ID: 28921602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic variants of XRCC1 and risk of hepatocellular carcinoma in chronic hepatitis C patients.
    Arafa M; Besheer T; El-Eraky AM; Abo El-Khair SM; Elsamanoudy AZ
    Br J Biomed Sci; 2019 Apr; 76(2):64-69. PubMed ID: 31025604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of Toll-Like Receptor 3 Single-Nucleotide Polymorphisms and Hepatitis C Virus Infection.
    Al-Anazi MR; Matou-Nasri S; Abdo AA; Sanai FM; Alkahtani S; Alarifi S; Alkahtane AA; Al-Yahya H; Ali D; Alessia MS; Alshahrani B; Al-Ahdal MN; Al-Qahtani AA
    J Immunol Res; 2017; 2017():1590653. PubMed ID: 28127569
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction Between Polymorphisms of IFN-γ and MICA Correlated with Hepatocellular Carcinoma.
    Li H; Liu F; Zhu H; Zhou X; Lu J; Chang H; Hu J
    Med Sci Monit; 2016 Feb; 22():549-53. PubMed ID: 26893439
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DEPDC5 variants increase fibrosis progression in Europeans with chronic hepatitis C virus infection.
    Burza MA; Motta BM; Mancina RM; Pingitore P; Pirazzi C; Lepore SM; Spagnuolo R; Doldo P; Russo C; Lazzaro V; Fischer J; Berg T; Aghemo A; Cheroni C; De Francesco R; Fargion S; Colombo M; Datz C; Stickel F; Valenti L; Romeo S
    Hepatology; 2016 Feb; 63(2):418-27. PubMed ID: 26517016
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TLR3 and TLR4 SNP variants in the liver disease resulting from hepatitis B virus and hepatitis C virus infection.
    Sghaier I; Zidi S; Mouelhi L; Ghazoueni E; Brochot E; Almawi WY; Loueslati BY
    Br J Biomed Sci; 2019 Jan; 76(1):35-41. PubMed ID: 30421643
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A common polymorphism in the NCAN gene is associated with hepatocellular carcinoma in alcoholic liver disease.
    Nischalke HD; Lutz P; Krämer B; Söhne J; Müller T; Rosendahl J; Fischer J; Berg T; Hittatiya K; Fischer HP; Soyka M; Semmo N; Nattermann J; Sauerbruch T; Strassburg CP; Stickel F; Spengler U
    J Hepatol; 2014 Nov; 61(5):1073-9. PubMed ID: 24946282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Large-scale search of single nucleotide polymorphisms for hepatocellular carcinoma susceptibility genes in patients with hepatitis C.
    Kato N; Ji G; Wang Y; Baba M; Hoshida Y; Otsuka M; Taniguchi H; Moriyama M; Dharel N; Goto T; Shao RX; Matsuura T; Ishii K; Shiina S; Kawabe T; Muramatsu M; Omata M
    Hepatology; 2005 Oct; 42(4):846-53. PubMed ID: 16175604
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of genetic polymorphism of BCL-2 (rs2279115) with susceptibility to HCV-related hepatocellular carcinoma.
    Ahmed HS; Wahab EA; Elhady HA; Elgerby MM
    Immunol Res; 2020 Aug; 68(4):189-197. PubMed ID: 32623689
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Independent and additive interaction between tumor necrosis factor β +252 polymorphisms and chronic hepatitis B and C virus infection on risk and prognosis of hepatocellular carcinoma: a case-control study.
    Jeng JE; Wu HF; Tsai MF; Tsai HR; Chuang LY; Lin ZY; Hsieh MY; Chen SC; Chuang WL; Wang LY; Yu ML; Dai CY; Tsai JF
    Asian Pac J Cancer Prev; 2014; 15(23):10209-15. PubMed ID: 25556449
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An intronic single nucleotide polymorphism in the MUTYH gene is associated with increased risk for HCV-induced hepatocellular carcinoma.
    Sakurada A; Miyanishi K; Tanaka S; Sato M; Sakamoto H; Kawano Y; Takada K; Nakabeppu Y; Kobune M; Kato J
    Free Radic Biol Med; 2018 Dec; 129():88-96. PubMed ID: 30218772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variations in DEPDC5 gene and its association with chronic hepatitis C virus infection in Saudi Arabia.
    Al-Anazi MR; Matou-Nasri S; Abdo AA; Sanai FM; Khan MQ; Albenmousa A; Al-Ashgar HI; Khalaf NZ; Al-Ahdal MN; Al-Qahtani AA
    BMC Infect Dis; 2014 Dec; 14():632. PubMed ID: 25551790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A variant in the MICA gene is associated with liver fibrosis progression in chronic hepatitis C through TGF-β1 dependent mechanisms.
    Sharkawy RE; Bayoumi A; Metwally M; Mangia A; Berg T; Romero-Gomez M; Abate ML; Irving WL; Sheridan D; Dore GJ; Spengler U; Lampertico P; Bugianesi E; Weltman M; Mollison L; Cheng W; Riordan S; Santoro R; Gallego-Durán R; Fischer J; Nattermann J; D'Ambrosio R; McLeod D; Powell E; Latchoumanin O; Thabet K; Najim MAM; Douglas MW; Liddle C; Qiao L; George J; Eslam M;
    Sci Rep; 2019 Feb; 9(1):1439. PubMed ID: 30723271
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of interleukin IL-6 rs-1474347 and IL-10 rs-1800896 genetic polymorphisms on the susceptibility of HCV-infected Egyptian patients to hepatocellular carcinoma.
    Abd El-Baky RM; Hetta HF; Koneru G; Ammar M; Shafik EA; Mohareb DA; Abbas El-Masry M; Ramadan HK; Abu Rahma MZ; Fawzy MA; Fathy M
    Immunol Res; 2020 Jun; 68(3):118-125. PubMed ID: 32504406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Single nucleotide polymorphism of rs2596542 and the risk of hepatocellular carcinoma development: A meta-analysis.
    Kuang XJ; Mo DC; Qin Y; Ahir BK; Wang JJ; Peng Z; Deng ZL
    Medicine (Baltimore); 2019 Mar; 98(11):e14767. PubMed ID: 30882647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.